Cerebral small vessel disease and blood pressure variability

Keywords: cerebral small vessel disease, blood pressure variability, arteriolosclerosis, MRI.


Annotation. Cerebral small vessel disease (CSVD) contributes up to about 25% of strokes and is the second most common cause of dementia and cognitive decline. Hypertensive arteriolosclerosis is the leading cause of CSVD, hence understanding its relationships with blood pressure changes, including blood pressure variability (BPV), is crucial. The aim of the research was to find out relationships between blood pressure parameters and such MRI-features of CSVD, as white matter hyperintensity (WMH), lacunes, perivascular spaces (PVS), brain atrophy in acute-stroke patients during hospitalization time. 160 participants enrolled in our study (56,3% were male, average age – 61,05±10,95, hospitalization time – 10,46 days). Statistical analysis was performed in the GNU Project software packages (2020). GNU PSPP (Version 1.4.1) [Computer Software]. Free Software Foundation. Boston, MA and The jamovi project (2021). Jamovi (Version 2.0) [Computer Software]. MRI was assessed according to “STRIVE” guidelines for cerebral vessel disease. We measured such BP parameters as mean systolic BP, mean diastolic BP, standard deviation and coefficient of variability for both systolic and diastolic BP. A moderate positive correlation was found between systolic BP variability and WMH severity (r=0.3, p=0.03). There was also a tendency for association between systolic BP variability and enlarged PVS at the basal ganglia level, but it was not significant (p=0.09). There was also a significant relationship between mean systolic BP and WMH severity (r=0.3, p<0.005), mean systolic BP and enlarged PVS at the basal ganglia level (r=0.3, p<0.01), mean systolic BP and total CSVD burden (r=0.3, p<0.005). Systolic BP and its variability are associated with WMH and enlarged PVS, which may provide valuable diagnostic and prognostic data about subtypes of CSVD and the consequences of vascular damage to the brain. Systolic BP variability targeting might be beneficial for prevention of CSVD progression.


[1] Cuadrado-Godia, E., Dwivedi, P., Sharma, S., Ois Santiago, A., Roquer Gonzalez, J., Balcells, M., … & Suri, J. S. (2018). Cerebral Small Vessel Disease: A Review Focusing on Pathophysiology, Biomarkers, and Machine Learning Strategies. Journal of stroke, 20(3), 302-320. https://doi.org/10.5853/jos.2017.02922

[2] Del Bene, A., Makin, S. D., Doubal, F. N., Inzitari, D., & Wardlaw, J. M. (2013). Variation in risk factors for recent small subcortical infarcts with infarct size, shape, and location. Stroke, 44(11), 3000-3006. https://doi.org/10.1161/STROKEAHA.113.002227

[3] Fazekas, F., Chawluk, J. B., Alavi, A., Hurtig, H. I., & Zimmerman, R. A. (1987). MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR. American journal of roentgenology, 149(2), 351-356. https://doi.org/10.2214/ajr.149.2.351

[4] Ghaznawi, R., Geerlings, M. I., Jaarsma-Coes, M., Hendrikse, J., & de Bresser, J. (2021). Association of White Matter Hyperintensity Markers on MRI and Long-term Risk of Mortality and Ischemic Stroke: The SMART-MR Study. Neurology, 96(17), e2172-e2183. https://doi.org/10.1212/WNL.0000000000011827

[5] Ghaznawi, R., Geerlings, M. I., Jaarsma-Coes, M. G., Zwartbol, M. H., Kuijf, H. J., van der Graaf, Y., … & de Bresser, J. (2019). The association between lacunes and white matter hyperintensity features on MRI: The SMART-MR study. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 39(12), 2486-2496. https://doi.org/10.1177/0271678X18800463

[6] Kerkhofs, D., Wong, S. M., Zhang, E., Staals, J., Jansen, J., van Oostenbrugge, R. J., & Backes, W. H. (2021). Baseline Blood-Brain Barrier Leakage and Longitudinal Microstructural Tissue Damage in the Periphery of White Matter Hyperintensities. Neurology, 96(17), e2192-e2200. https://doi.org/10.1212/WNL.0000000000011783

[7] Klarenbeek, P., van Oostenbrugge, R. J., Rouhl, R. P., Knottnerus, I. L., & Staals, J. (2013). Ambulatory blood pressure in patients with lacunar stroke: association with total MRI burden of cerebral small vessel disease. Stroke, 44(11), 2995-2999. https://doi.org/10.1161/STROKEAHA.113.002545

[8] Litak, J., Mazurek, M., Kulesza, B., Szmygin, P., Litak, J., Kamieniak, P., & Grochowski, C. (2020). Cerebral Small Vessel Disease. International journal of molecular sciences, 21(24), 9729. https://doi.org/10.3390/ijms21249729

[9] Ma, Y., Song, A., Viswanathan, A., Blacker, D., Vernooij, M. W., Hofman, A., & Papatheodorou, S. (2020). Blood Pressure Variability and Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts. Stroke, 51(1), 82-89. https://doi.org/10.1161/STROKEAHA.119.026739

[10] Pantoni, L. (2010). Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. The Lancet. Neurology, 9(7), 689-701. https://doi.org/10.1016/S1474-4422(10)70104-6

[11] Potter, G. M., Chappell, F. M., Morris, Z., & Wardlaw, J. M. (2015). Cerebral perivascular spaces visible on magnetic resonance imaging: development of a qualitative rating scale and its observer reliability. Cerebrovascular diseases (Basel, Switzerland), 39(3-4), 224-231. https://doi.org/10.1159/000375153

[12] Sato, S., Delcourt, C., Heeley, E., Arima, H., Zhang, S., Al-Shahi Salman, R., … & Anderson, C. S. (2016). Significance of Cerebral Small-Vessel Disease in Acute Intracerebral Hemorrhage. Stroke, 47(3), 701-707. https://doi.org/10.1161/STROKEAHA.115.012147

[13] Regenhardt, R. W., Das, A. S., Lo, E. H., & Caplan, L. R. (2018). Advances in Understanding the Pathophysiology of Lacunar Stroke: A Review. JAMA neurology, 75(10), 1273-1281. https://doi.org/10.1001/jamaneurol.2018.1073

[14] Wahlund, L. O., Westman, E., van Westen, D., Wallin, A., Shams, S., Cavallin, L., & Larsson, E. M. (2017). Imaging biomarkers of dementia: recommended visual rating scales with teaching cases. Insights into imaging, 8(1), 79-90. https://doi.org/10.1007/s13244-016-0521-6

[15] Wardlaw, J. M., Smith, E. E., Biessels, G. J., Cordonnier, C., Fazekas, F., Frayne, R., … & Greenberg, S. (2013). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. The Lancet. Neurology, 12(8), 822-838. https://doi.org/10.1016/S1474-4422(13)70124-8
How to Cite
Bartiuk, R. S. (2022). Cerebral small vessel disease and blood pressure variability. Reports of Vinnytsia National Medical University, 26(1), 53-58. https://doi.org/https://doi.org/10.31393/reports-vnmedical-2022-26(1)-10